Trials / Completed
CompletedNCT01824225
Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration
Study of PRN and Every 2months Intravitreal Aflibercept After 3 Initial Monthly Injection for Age Related Macular Degeneration
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Nihon University · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial monthly intravitreal aflibercept for the Japanese age related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aflibercept |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-03-01
- Completion
- 2015-03-01
- First posted
- 2013-04-04
- Last updated
- 2015-10-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01824225. Inclusion in this directory is not an endorsement.